Rating Change
Citigroup analysts downgraded Accendra Health, Inc. (NYSE:ACH) from Buy to Neutral on August 11, 2026.
Citigroup analysts downgraded Accendra Health, Inc. (NYSE:ACH) from Buy to Neutral on August 11, 2026.

At publication ·
Accendra Health, Inc. (NYSE:ACH) · downgrade
At a glance
Citigroup analysts downgraded Accendra Health, Inc. (NYSE:ACH) from Buy to Neutral on August 11, 2026.
Accendra Health, Inc. operates in the Healthcare sector. The stock currently trades at $1.26 with a market capitalization of $187.2M.
Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Citigroup's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 5 Buy, 4 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 11, 2026 | Citigroup | Neutral | N/A |
| Jul 24, 2026 | Citigroup | Buy | N/A |
| May 12, 2026 | Baird | Outperform | N/A |
| May 12, 2026 | Citigroup | Buy | N/A |
| May 12, 2026 | UBS | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View ACH Stock Page
A rating of Neutral from Citigroup reflects the analyst's outlook on Accendra Health, Inc. (NYSE:ACH). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ACH forecast page.
Current market data
NYSE · ACH
$1.08
Up: +$0.01 · +0.93%
Live quote updated
Keep reading